One RCT [43] tested the efficacy of donepezil chlorhydrate, a cholinesterase inhibitor which has shown neuroprotective and anti-inflammatory effects and is approved for the treatment of Alzheimer’s disease [80, 81]. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.